Stay updated on Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial
Sign up to get notified when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.

Latest updates to the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov page now displays the pancreatic cancer immunotherapy study record, including its treatment arms, eligibility criteria, outcomes, and record dates, instead of a 403 Forbidden message.SummaryDifference57%

- Check15 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide notice announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study details with an access-restriction notice.SummaryDifference20%

Stay in the know with updates to Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.